INCR
InterCure Ltd.
5.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in ILS.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.23 | -14.64 | -17.92 | -10.98 | -5.86 | -0.96 | -0.45 | -0.27 | -0.36 | -0.86 | 1.54 | 3.06 | 5.65 | -5.88 | -7.01 | 1.48 | |
| 8.46 | 3.82 | 1.28 | 0.47 | 0.07 | – | – | 0.00 | 0.00 | 0.00 | 0.64 | 0.91 | 1.29 | 1.44 | 1.61 | 1.51 | |
| 3.62 | -10.95 | 8.25 | -0.70 | – | 0.19 | 0.01 | 0.00 | 1.90 | 13.93 | 1.97 | 0.79 | 0.98 | 0.28 | 0.24 | 0.21 | |
| – | – | – | – | – | – | – | 1.35 | 2.52 | -1.92 | 9.04 | 1.79 | – | – | – | – | |
| 23.73 | 21.70 | -3.93 | -4.01 | 0.85 | -0.21 | -0.04 | -0.02 | 0.23 | -0.14 | -0.81 | -0.20 | -0.33 | -4.78 | -0.96 | 1.66 | |
| 0.00 | 0.26 | 3.42 | 0.86 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 4.10 | 1.72 | 2.18 | 0.29 | 0.46 | 0.31 | |
| 8.58 | 5.64 | -3.04 | 2.40 | 2.77 | -5.29 | -4.25 | -0.66 | -1.93 | -8.27 | -4.48 | -7.98 | -15.71 | 0.52 | 1.85 | -0.18 | |
| – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | 0.27 | 2.12 | -0.11 | -2.67 | 8.06 | 15.18 | -6.80 | 0.81 | -2.56 | |
| 30.20 | 12.96 | 49.17 | – | 1.08 | 7.47 | 4.76 | 0.84 | 2.58 | 14.20 | 4.98 | 24.23 | 13.28 | -9.09 | 2.77 | -4.11 | |
| -15.46 | 3.95 | 28.22 | -8.57 | -2.01 | 1.41 | 0.05 | -0.12 | 0.29 | 4.71 | 2.08 | 19.38 | 4.01 | -14.42 | -2.39 | -2.80 | |
| -54.23 | -14.90 | -21.34 | -11.84 | -5.86 | -0.96 | -0.46 | -0.27 | -0.38 | -0.86 | -2.57 | 1.35 | 3.48 | -6.17 | -7.46 | 1.17 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.